Fmr LLC Denali Therapeutics Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Fmr LLC holds 234,870 shares of DNLI stock, worth $7.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

234,870

Previous 1,232,522 80.94%

Holding current value

$7.29 Million

Previous $25.3 Million 78.44%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$14.96 - $23.22 $14.9 Million - $23.2 Million	-997,652 Reduced 80.94%	234,870 $5.45 Million
Q1 2024 May 13, 2024	BUY	$15.83 - $23.35 $9.35 Million - $13.8 Million	590,869 Added 92.09%	1,232,522 $25.3 Million
Q4 2023 Feb 13, 2024	SELL	$16.2 - $23.18 $6.75 Million - $9.66 Million	-416,844 Reduced 39.38%	641,653 $13.8 Million
Q3 2023 Nov 13, 2023	SELL	$20.63 - $30.17 $440,656 - $644,431	-21,360 Reduced 1.98%	1,058,497 $21.8 Million
Q2 2023 Aug 11, 2023	SELL	$23.37 - $32.96 $320,332 - $451,782	-13,707 Reduced 1.25%	1,079,857 $31.9 Million
Q1 2023 May 11, 2023	SELL	$21.91 - $32.67 $24.5 Million - $36.6 Million	-1,120,230 Reduced 50.6%	1,093,564 $25.2 Million
Q4 2022 Feb 13, 2023	SELL	$26.28 - $33.92 $6.27 Million - $8.1 Million	-238,662 Reduced 9.73%	2,213,794 $61.6 Million
Q3 2022 Nov 10, 2022	SELL	$25.97 - $38.53 $10.8 Million - $16.1 Million	-417,284 Reduced 14.54%	2,452,456 $75.3 Million
Q2 2022 Aug 12, 2022	SELL	$20.88 - $35.19 $1.55 Million - $2.62 Million	-74,315 Reduced 2.52%	2,869,740 $84.5 Million
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $224,344 - $365,680	-7,736 Reduced 0.26%	2,944,055 $94.7 Million
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $11.8 Million - $15.2 Million	276,042 Added 10.32%	2,951,791 $132 Million
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $323,167 - $521,481	6,666 Added 0.25%	2,675,749 $135 Million
Q2 2021 Aug 13, 2021	BUY	$50.3 - $78.44 $134 Million - $209 Million	2,669,083 New	2,669,083 $209 Million

Others Institutions Holding DNLI

# of Institutions

214

Shares Held

121M

Call Options Held

127K

Put Options Held

38.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $4.17B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account